BL-B01D1

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

39 regulatory and trial events tracked for BL-B01D1, covering 2025-05-07 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07) [Phase 3]

See pricing